Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
12.89
-0.07 (-0.54%)
At close: Apr 28, 2026, 4:00 PM EDT
12.89
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:33 PM EDT
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $464.04 million as of April 28, 2026. Its market cap has increased by 65.93% in one year.
Market Cap
464.04M
Enterprise Value
219.27M
1-Year Change
65.93%
Ranking
Category
Stock Price
$12.89
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $464.04M, an increase of 84.87%. That is a compound annual growth rate of 14.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 466.56M | 26.56% |
| Dec 31, 2025 | 368.66M | -39.78% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Armata Pharmaceuticals | 473.30M |
| Prelude Therapeutics | 472.60M |
| Larimar Therapeutics | 471.63M |
| Valneva SE | 470.89M |
| Aura Biosciences | 466.73M |
| Contineum Therapeutics | 463.34M |
| Ginkgo Bioworks Holdings | 458.09M |
| REGENXBIO | 452.17M |